Absorption Systems is a nonclinical CRO emphasizing the most highly relevant physiological models to further research accuracy from post-discovery through post-market surveillance. We partner with you to overcome ADMET barrier in the development of drugs and devices to improve human outcomes. Our research covers in vivo, ex vivo, in vitro from R&D through commercial GMP. Absorption Systems, ACF Division provides analytical support for in vivo and ex vivo gene therapies, cell therapies and immunotherapies, CAR-T, T-Cell – in vitro cell based potency assay development, in vivo biodistribution, toxicology and efficacy. ACF provides GMP-compliant gene/cell therapy commercial potency release testing at its FDA/MHRA inspected facility.